ReviewWorld journal of gastroenterology2022
Current status of minimally invasive liver surgery for cancers.
Review in World journal of gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.
- Analgesic efficacy of multiple regional nerve block techniques in laparoscopic hepatectomy: a systematic review and meta-analysis.BMC anesthesiology · 2026Pooled it
- Review
- Risk of Long-Term Survival After Hepatic Resection for Hepatocellular and Intrahepatic Cholangiocarcinoma: Population-Based Analysis in Korea.Journal of Korean medical science · 2026Article
- Evolution of two-stage hepatectomy: 25 years of modifications and lessons learned.Hepatobiliary surgery and nutrition · 2026Article
- Multicenter study on right Glissonean pedicle management in laparoscopic right hepatectomy: main trunk vs. sectoral pedicle transection approaches.Surgical endoscopy · 2026Article
- Utility of liver surface-guided encirclement of hepatoduodenal ligament for the Pringle maneuver in minimally invasive repeat liver resection.World journal of gastroenterology · 2026Article
- Eco-Friendly Approaches in Oncology: Developing Holmium (ACS omega · 2025Article
- Experience-based transition to robotic surgery in an experienced program in minimally invasive hepatobiliary surgery.Surgical endoscopy · 2024Article
- A Decade of Experience Between Open and Minimally Invasive Hepatectomies for Hepatocellular Carcinoma.Medicina (Kaunas, Lithuania) · 2024Article
- Laparoscopic Liver Resection Utilizing a Water Jet Scalpel for Patients With Liver Fibrosis.Cureus · 2023Article
- Editorial (Preface) for the Special Issue on Advances in Minimally Invasive Liver Resection for Cancer Therapies.Cancers · 2023Article
- Article
- Compliance with enhanced recovery after surgery predicts long-term outcome after hepatectomy for cholangiocarcinoma.World journal of gastrointestinal surgery · 2023Article
- Laparoscopic Repeat Liver Resection-Selecting the Best Approach for Repeat Liver Resection.Cancers · 2023Review
- Editorial: Interdisciplinary surgical strategies for complex tumor defects in modern oncology.Frontiers in oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocellular carcinoma (HCC) patients have chronic liver disease with functional deterioration and multicentric oncogenicity. Liver surgeries for the patients should be planned on both oncological effects and sparing liver function. In colorectal patients with post-chemotherapy liver injury and multiple bilateral tumors, handling multiple tumors in a fragile/easy-to-bleed liver is an important issue. Liver surgery for biliary tract cancers is often performed as a resection of large-volume functioning liver with extensive lymphadenectomy and bile duct resection/reconstruction. Minimally invasive liver surgery (MILS) for HCC is applied with the advantages of laparoscopic for cases of cirrhosis or repeat resections. Small anatomical resections using the Glissonian, indocyanine green-guided, and hepatic vein-guided approaches are under discussion. In many cases of colorectal liver metastases, MILS is applied combined with chemotherapy owing to its advantage of better hemostasis. Two-stage hepatectomy and indocyanine green-guided tumor identification for multiple bilateral tumors are under discussion. In the case of biliary tract cancers, MILS with extensive lymphadenectomy and bile duct resection/reconstruction are developing. A robot-assisted procedure for dissection of major vessels and handling fragile livers may have advantages, and well-simulated robot-assisted procedure may decrease the difficulty for biliary tract cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.